When long-term users of prescription opioids in Canada were mailed a brochure encouraging them to cut their dosages, many of them did – and that's a good thing, researchers say.
A new form of cognitive-behavioural couple therapy may help women diagnosed with sexual desire disorders and reduce the emotional distress associated with it.
The discovery of the role played by β-arrestins in the formation of the spinal cord at the embryonic stage opens up the prospect of exploring mechanisms that could repair spinal cord damage.
Michel Bouvier, CEO of the IRIC for the past 10 years, is delighted to see his model of combining basic research with drug discovery and commercialization bearing fruit.
For the first time, a team co-led by Alexey Pshezhetsky resolved the structure of the enzyme deficient in Sanfilippo disease, a rare pediatric neurodegenerative disorder.
On a closed-off street in front of École Saint-Benoît in Ahuntsic, several hundred kids are free to play after school thanks to a pilot project co-developed at UdeM's School of Public Health.
Katherine Frohlich talks about her new role shepherding over $8 million a year in federal funding for research as the new scientific director of Canada's Institute of Population and Public Health.
